Clinical Research & Governance
Responsible translation requires disciplined clinical safety, ethics-led study design, regulatory awareness, and longitudinal patient monitoring.
Safety & Translation Protocol
Biodistribution & Dosing
Comprehensive pharmacokinetic and biodistribution profiling prior to clinical initiation.
Immune Monitoring
In-depth assessment of neutralizing antibodies, T-cell responses, and systemic tolerance.
Patient Stratification
Genomic and biomarker-guided eligibility screening to ensure targeted benefit.
Long-term Registries
Standardized multi-year follow-up registries to monitor durability and safety outcomes.
Governance Standards
Good Clinical Practice
Strict compliance with international ethical and scientific quality standards.
Ethics Board Oversight
Independent review and institutional ethics approval across all active studies.
Data Integrity
Standardized electronic case report forms and secure audit-ready registries.
Safety Reporting
Rapid pharmacovigilance and transparent adverse event escalation pathways.
For clinical trial collaboration or research inquiries.